Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2010 4
2011 8
2012 8
2013 1
2014 5
2015 3
2016 10
2017 9
2018 9
2019 7
2020 9
2021 12
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Among authors: lora d. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, Alonso-Curbelo D, Suarez J, Osterloh L, Graña O, Mulero F, Megías D, Cañamero M, Martínez-Torrecuadrada JL, Mondal C, Di Martino J, Lora D, Martinez-Corral I, Bravo-Cordero JJ, Muñoz J, Puig S, Ortiz-Romero P, Rodriguez-Peralto JL, Ortega S, Soengas MS. Olmeda D, et al. Among authors: lora d. Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977. Nature. 2017. PMID: 28658220 Free PMC article.
Does bariatric surgery decrease gastric cancer risk?
Menéndez P, Padilla D, Villarejo P, Menéndez JM, Lora D. Menéndez P, et al. Among authors: lora d. Hepatogastroenterology. 2012 Mar-Apr;59(114):409-12. doi: 10.5754/hge10390. Hepatogastroenterology. 2012. PMID: 22353507 Review.
Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti-PD-1/PD-L1 Therapy.
Carril-Ajuria L, Lora D, Carretero-González A, Martín-Soberón M, Rioja-Viera P, Castellano D, de Velasco G. Carril-Ajuria L, et al. Among authors: lora d. Clin Genitourin Cancer. 2021 Apr;19(2):95-102. doi: 10.1016/j.clgc.2020.10.004. Epub 2020 Oct 15. Clin Genitourin Cancer. 2021. PMID: 33189597 Review.
The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials.
Carretero-González A, Lora D, Martín Sobrino I, Sáez Sanz I, Bourlon MT, Anido Herranz U, Martínez Chanzá N, Castellano D, de Velasco G. Carretero-González A, et al. Among authors: lora d. Cancers (Basel). 2020 Jul 17;12(7):1945. doi: 10.3390/cancers12071945. Cancers (Basel). 2020. PMID: 32709062 Free PMC article. Review.
Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa.
Corbella L, Boán J, San-Juan R, Fernández-Ruiz M, Carretero O, Lora D, Hernández-Jiménez P, Ruiz-Ruigómez M, Rodríguez-Goncer I, Silva JT, López-Medrano F, Lizasoain M, Villa J, Caro-Teller JM, Aguado JM. Corbella L, et al. Among authors: lora d. Int J Antimicrob Agents. 2022 Jan 3:106517. doi: 10.1016/j.ijantimicag.2021.106517. Online ahead of print. Int J Antimicrob Agents. 2022. PMID: 34990760
75 results